We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$14.8B
AUM Growth
+$2.92B
Cap. Flow
+$3.28B
Cap. Flow %
22.14%
Top 10 Hldgs %
12.56%
Holding
1,029
New
443
Increased
269
Reduced
185
Closed
112

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$217M
2
AAPL icon
Apple
AAPL
+$208M
3
MSFT icon
Microsoft
MSFT
+$199M
4
AMZN icon
Amazon
AMZN
+$136M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$133M

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$125M
2
GILD icon
Gilead Sciences
GILD
+$107M
3
PR
Permian Resources
PR
+$85.4M
4
RDDT icon
Reddit
RDDT
+$84.1M
5
KEYS icon
Keysight
KEYS
+$79M

Sector Composition

Rank Sector Weight
1 Healthcare 31.96%
2 Technology 25.64%
3 Financials 7.58%
4 Industrials 6.88%
5 Communication Services 6.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLTR icon
776
Dollar Tree
DLTR
$24.7B
$910K 0.01%
+12,137
New +$833K
ARE icon
777
Alexandria Real Estate Equities
ARE
$8.73B
$907K 0.01%
+9,301
New +$1.02M
ELV icon
778
Elevance Health
ELV
$84.8B
$894K 0.01%
+2,424
New +$1.01M
CF icon
779
CF Industries
CF
$17.9B
$892K 0.01%
+10,451
New +$904K
UBER icon
780
Uber
UBER
$139B
$865K 0.01%
+14,346
New +$1.02M
APTV icon
781
Aptiv
APTV
$9.95B
$854K 0.01%
+14,115
New +$864K
PHVS icon
782
Pharvaris
PHVS
$2.34B
$853K 0.01%
+44,514
New +$916K
EVRG icon
783
Evergy
EVRG
$19.1B
$850K 0.01%
+13,811
New +$854K
DOC icon
784
Healthpeak Properties
DOC
$15B
$848K 0.01%
+41,824
New +$906K
DRI icon
785
Darden Restaurants
DRI
$23.9B
$843K 0.01%
+4,516
New +$757K
VIGL
786
DELISTED
Vigil Neuroscience
VIGL
$831K 0.01%
488,756
+344,614
+239% +$1.02M
MRSH
787
Marsh
MRSH
$91.4B
$821K 0.01%
+3,864
New +$857K
AMCR icon
788
Amcor
AMCR
$22.1B
$817K 0.01%
+17,360
New +$907K
EMR icon
789
Emerson Electric
EMR
$91B
$797K 0.01%
6,431
-381,484
-98% -$46.3M
CAG icon
790
Conagra Brands
CAG
$7.18B
$795K 0.01%
+28,662
New +$814K
ROL icon
791
Rollins
ROL
$18.1B
$782K 0.01%
+16,869
New +$826K
EW icon
792
Edwards Lifesciences
EW
$51.2B
$773K 0.01%
10,441
-342,796
-97% -$24M
JKHY icon
793
Jack Henry & Associates
JKHY
$11B
$768K 0.01%
+4,381
New +$783K
PRAX icon
794
Praxis Precision Medicines
PRAX
$8.9B
$766K 0.01%
+9,948
New +$720K
KMX icon
795
CarMax
KMX
$8.04B
$761K 0.01%
+9,304
New +$731K
ATAI icon
796
AtaiBeckley Inc
ATAI
$2.67B
$748K 0.01%
562,372
+27,325
+5% +$36.3K
CHRW icon
797
C.H. Robinson
CHRW
$17.9B
$733K 0.01%
+7,099
New +$764K
GUTS icon
798
Fractyl Health
GUTS
$109M
$723K ﹤0.01%
351,135
-68,840
-16% -$160K
REG icon
799
Regency Centers
REG
$14.5B
$722K ﹤0.01%
+9,769
New +$715K
SJM icon
800
J.M. Smucker
SJM
$12.7B
$704K ﹤0.01%
+6,390
New +$735K

Similar funds

Woodline Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Woodline Partners held 1,029 positions worth $14.8B, up 25% from $11.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Woodline Partners deployed $3.28B of net new capital in Q4 2024, opening 443 new positions and adding to 269 existing holdings. Its largest new stake was TE Connectivity: 890,754 shares worth $127M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 43% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $107M trimmed.

  • Woodline Partners's largest Q4 2024 buy was TE Connectivity: 890,754 shares worth $127M.
  • Woodline Partners added most to NVIDIA in Q4 2024, an estimated $217M increase.
  • Woodline Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $107M.
  • Woodline Partners fully exited ASML in Q4 2024, selling an estimated $125M.
  • Woodline Partners's ten largest holdings make up 13% of its $14.8B portfolio in Q4 2024.
  • Woodline Partners opened 443 new positions and closed 112 in Q4 2024.
  • Woodline Partners's portfolio value rose 25% quarter-over-quarter to $14.8B.

Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.